2 assets in Respiratory Tract Infectious Disorder

Therapeutic assets addressing Respiratory Tract Infectious Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
XENON Respiratory Tract Infectious Disorder	Mario Castro, MD, MPH	P1	CC (43)
Rsp-1502 Respiratory Tract Infectious Disorder	Respirion Pharmaceuticals Pty Ltd	P1/2	NR ()